![ASCO14 - Poster: Activity of abiraterone acetate in metastatic castration-resistant prostate cancer patients previously treated with ketoconazole: A prospective phase II study from the Prostate Cancer Clinical Trials Consortium ASCO14 - Poster: Activity of abiraterone acetate in metastatic castration-resistant prostate cancer patients previously treated with ketoconazole: A prospective phase II study from the Prostate Cancer Clinical Trials Consortium](https://www.urotoday.com/images/stories/conferences/asco/asco_2014_kim_poster.jpg)
ASCO14 - Poster: Activity of abiraterone acetate in metastatic castration-resistant prostate cancer patients previously treated with ketoconazole: A prospective phase II study from the Prostate Cancer Clinical Trials Consortium
![Tempus Selected as Sequencing and Analytics Provider by the Prostate Cancer Clinical Trials Consortium forPhase II Clinical Trial - Tempus Tempus Selected as Sequencing and Analytics Provider by the Prostate Cancer Clinical Trials Consortium forPhase II Clinical Trial - Tempus](https://prismic-io.s3.amazonaws.com/tempus-20/ab2f0a5f6e3d9312c1a5977c42a0a0acd3acebec_pcctc_081417_article.jpg)
Tempus Selected as Sequencing and Analytics Provider by the Prostate Cancer Clinical Trials Consortium forPhase II Clinical Trial - Tempus
![Translating clinical trials to clinical practice: outcomes of men with metastatic castration resistant prostate cancer treated with docetaxel and prednisone in and out of clinical trials* - Annals of Oncology Translating clinical trials to clinical practice: outcomes of men with metastatic castration resistant prostate cancer treated with docetaxel and prednisone in and out of clinical trials* - Annals of Oncology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/cb446b4f-c6bb-4a8b-9661-21b4b9143db7/gr1.jpg)
Translating clinical trials to clinical practice: outcomes of men with metastatic castration resistant prostate cancer treated with docetaxel and prednisone in and out of clinical trials* - Annals of Oncology
WIRB-Copernicus Group and the Prostate Cancer Clinical Trials Consortium Announce New Partnership to Improve Efficiency of Oncology Research Reviews
![Pharmaceuticals | Free Full-Text | Current Status of PSMA-Radiotracers for Prostate Cancer: Data Analysis of Prospective Trials Listed on ClinicalTrials.gov | HTML Pharmaceuticals | Free Full-Text | Current Status of PSMA-Radiotracers for Prostate Cancer: Data Analysis of Prospective Trials Listed on ClinicalTrials.gov | HTML](https://www.mdpi.com/pharmaceuticals/pharmaceuticals-13-00012/article_deploy/html/images/pharmaceuticals-13-00012-g003.png)
Pharmaceuticals | Free Full-Text | Current Status of PSMA-Radiotracers for Prostate Cancer: Data Analysis of Prospective Trials Listed on ClinicalTrials.gov | HTML
![Access and Representation: A Narrative Review of the Disparities in Access to Clinical Trials and Precision Oncology in Black men with Prostate Cancer - Urology Access and Representation: A Narrative Review of the Disparities in Access to Clinical Trials and Precision Oncology in Black men with Prostate Cancer - Urology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/asset/a2468be3-10a7-4ee2-909e-f0317f6fd55e/gr1.jpg)
Access and Representation: A Narrative Review of the Disparities in Access to Clinical Trials and Precision Oncology in Black men with Prostate Cancer - Urology
![Radiotherapy to the primary tumour for newly diagnosed, metastatic prostate cancer (STAMPEDE): a randomised controlled phase 3 trial - The Lancet Radiotherapy to the primary tumour for newly diagnosed, metastatic prostate cancer (STAMPEDE): a randomised controlled phase 3 trial - The Lancet](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/b07a899e-dd29-4693-b4c2-59e3a48a0384/gr1.gif)
Radiotherapy to the primary tumour for newly diagnosed, metastatic prostate cancer (STAMPEDE): a randomised controlled phase 3 trial - The Lancet
![The Evolving Biology of Castration-Resistant Prostate Cancer: Review of Recommendations From the Prostate Cancer Clinical Trials Working Group 3 The Evolving Biology of Castration-Resistant Prostate Cancer: Review of Recommendations From the Prostate Cancer Clinical Trials Working Group 3](https://cdn.sanity.io/images/0vv8moc6/cancernetwork/0f5514f14728c821be657af58a78a3fa23523c2d-756x474.png)